Oncology & Cancer

Novel bioassay predicts cancer patients' response to immunotherapy

A team of researchers from Ben-Gurion University of the Negev (BGU) has developed a groundbreaking bio-sensing technology that predicts the response of cancer patients to anti-PD1, an immune checkpoint inhibitor (ICI) therapy, ...

Oncology & Cancer

Blood-based 'liquid biopsy' might spot early-stage cancers

An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy—including some that are particularly tricky to detect, a preliminary study suggests.

page 3 from 24